These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 17013570)

  • 1. Quality assurance in the EORTC randomized trial 22922/10925 investigating the role of irradiation of the internal mammary and medial supraclavicular lymph node chain works.
    Poortmans P; Kouloulias V; van Tienhoven G; Collette L; Struikmans H; Venselaar JL; Van den Bogaert W; Davis JB; Lambin P;
    Strahlenther Onkol; 2006 Oct; 182(10):576-82. PubMed ID: 17013570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality assurance in the 22991 EORTC ROG trial in localized prostate cancer: dummy run and individual case review.
    Matzinger O; Poortmans P; Giraud JY; Maingon P; Budiharto T; van den Bergh AC; Davis JB; Musat E; Ataman F; Huyskens DP; Gulyban A; Bolla M;
    Radiother Oncol; 2009 Mar; 90(3):285-90. PubMed ID: 19038468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EORTC 22972-26991/MRC BR10 trial: fractionated stereotactic boost following conventional radiotherapy of high grade gliomas. Clinical and quality-assurance results of the stereotactic boost arm.
    Baumert BG; Brada M; Bernier J; Kortmann RD; Dehing-Oberije C; Collette L; Davis JB
    Radiother Oncol; 2008 Aug; 88(2):163-72. PubMed ID: 18455252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dummy run of quality assurance program in a phase 3 randomized trial investigating the role of internal mammary lymph node irradiation in breast cancer patients: Korean Radiation Oncology Group 08-06 study.
    Chung Y; Kim JW; Shin KH; Kim SS; Ahn SJ; Park W; Lee HS; Kim DW; Lee KC; Suh HS; Kim JH; Shin HS; Kim YB; Suh CO
    Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):419-26. PubMed ID: 25636764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The potential impact of treatment variations on the results of radiotherapy of the internal mammary lymph node chain: a quality-assurance report on the dummy run of EORTC Phase III randomized trial 22922/10925 in Stage I--III breast cancer(1).
    Poortmans PM; Venselaar JL; Struikmans H; Hurkmans CW; Davis JB; Huyskens D; van Tienhoven G; Vlaun V; Lagendijk JJ; Mijnheer BJ; De Winter KA; Van der Hulst MH; Van den Bogaert WF
    Int J Radiat Oncol Biol Phys; 2001 Apr; 49(5):1399-408. PubMed ID: 11286848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality assurance in breast cancer: EORTC experiences in the phase III trial on irradiation of the internal mammary nodes.
    Musat E; Poortmans P; Van den Bogaert W; Struikmans H; Fourquet A; Bartelink H; Kirkove C; Budach V; Pierart M; Collette L
    Eur J Cancer; 2007 Mar; 43(4):718-24. PubMed ID: 17240136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality assurance of the 22961 EORTC trial. A phase III study of the optimal combination of hormonal adjuvant treatment by LHRH analogue and radiation therapy for the management of locally advanced prostate cancer: the dummy run.
    Kouloulias VE; Giraud JY; Davis BJ; Dusserre A; Zurlo A; Bolla M
    Radiother Oncol; 2004 Oct; 73(1):11-20. PubMed ID: 15465141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality assurance of axillary radiotherapy in the EORTC AMAROS trial 10981/22023: the dummy run.
    Hurkmans CW; Borger JH; Rutgers EJ; van Tienhoven G; ;
    Radiother Oncol; 2003 Sep; 68(3):233-40. PubMed ID: 13129630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality assurance in the EORTC phase III randomised 'boost vs. no boost' trial for breast conserving therapy: comparison of the results of two individual case reviews performed early and late during the accrual period.
    Poortmans PM; Ataman F; Davis JB; Bartelink H; Horiot JC; Pierart M; Collette L; Van Tienhoven G
    Radiother Oncol; 2005 Sep; 76(3):278-84. PubMed ID: 15919127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postoperative irradiation in breast cancer patients with one to three positive axillary lymph nodes. Is there an impact of axillary extranodal tumor extension on locoregional and distant control?
    Stranzl H; Ofner P; Peintinger F
    Strahlenther Onkol; 2006 Oct; 182(10):583-8. PubMed ID: 17013571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A glance on quality assurance in EORTC study 22922 evaluating techniques for internal mammary and medial supraclavicular lymph node chain irradiation in breast cancer.
    Lievens Y; Poortmans P; Van den Bogaert W
    Radiother Oncol; 2001 Sep; 60(3):257-65. PubMed ID: 11514005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DEGRO practical guidelines for radiotherapy of breast cancer II. Postmastectomy radiotherapy, irradiation of regional lymphatics, and treatment of locally advanced disease.
    Sautter-Bihl ML; Souchon R; Budach W; Sedlmayer F; Feyer P; Harms W; Haase W; Dunst J; Wenz F; Sauer R
    Strahlenther Onkol; 2008 Jul; 184(7):347-53. PubMed ID: 19016032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality assurance of EORTC trial 22922/10925 investigating the role of internal mammary--medial supraclavicular irradiation in stage I-III breast cancer: the individual case review.
    Poortmans P; Kouloulias VE; Venselaar JL; Struikmans H; Davis JB; Huyskens D; van Tienhoven G; Hurkmans C; Mijnheer B; Van den Bogaert W
    Eur J Cancer; 2003 Sep; 39(14):2035-42. PubMed ID: 12957458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detailed review and analysis of complex radiotherapy clinical trial planning data: evaluation and initial experience with the SWAN software system.
    Ebert MA; Haworth A; Kearvell R; Hooton B; Coleman R; Spry N; Bydder S; Joseph D
    Radiother Oncol; 2008 Feb; 86(2):200-10. PubMed ID: 18077034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nodal ratios in node-positive breast cancer--long-term study to clarify discrepancy of role of supraclavicular and axillary regional radiotherapy.
    Tai P; Joseph K; Sadikov E; Mahmood S; Lien F; Yu E
    Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):662-6. PubMed ID: 17449196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality assurance of the EORTC 22043-30041 trial in post-operative radiotherapy in prostate cancer: results of the Dummy Run procedure.
    Fenton PA; Hurkmans C; Gulyban A; van der Leer J; Matzinger O; Poortmans P; Collette L; Bolla M
    Radiother Oncol; 2013 Jun; 107(3):346-51. PubMed ID: 23707151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality assurance of the PREOPANC trial (2012-003181-40) for preoperative radiochemotherapy in pancreatic cancer : The dummy run.
    Versteijne E; Lens E; van der Horst A; Bel A; Visser J; Punt CJA; Suker M; van Eijck CHJ; van Tienhoven G
    Strahlenther Onkol; 2017 Aug; 193(8):630-638. PubMed ID: 28608305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Irradiation of lymph nodes areas in breast cancer].
    Hennequin C; Romestaing P; Maylin C
    Cancer Radiother; 2008 Nov; 12(6-7):559-64. PubMed ID: 18951822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Centralized medical monitoring in phase III clinical trials: the National Surgical Adjuvant Breast and Bowel Project (NSABP) experience.
    Soran A; Nesbitt L; Mamounas EP; Lembersky B; Bryant J; Anderson S; Brown A; Passarello M
    Clin Trials; 2006; 3(5):478-85. PubMed ID: 17060221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality assurance of radiotherapy in a clinical trial for lymphoma: individual case review.
    Shikama N; Oguchi M; Isobe K; Nakamura K; Tamaki Y; Hasegawa M; Kodaira T; Sasaki S; Kagami Y;
    Anticancer Res; 2007; 27(4C):2621-5. PubMed ID: 17695424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.